电子鼻与线虫鼻——新型早期癌症筛查工具

国际肿瘤学杂志››2024,Vol. 51››Issue (4): 223-226.doi:10.3760/cma.j.cn371439-20230616-00037

电子鼻与线虫鼻——新型早期癌症筛查工具

胡婷婷, 王越华()

湖北文理学院附属医院襄阳市中心医院肿瘤科，襄阳 441021

收稿日期:2023-06-16修回日期:2023-10-16出版日期:2024-04-08发布日期:2024-05-10
通讯作者:王越华，Email： 510839835@qq.com
基金资助:
湖北省卫生健康委指导性项目(WJ2019F091)

Electronic nose and nematode nose as new tool for early cancer screening

Hu Tingting, Wang Yuehua()

Department of Oncology， Xiangyang Central Hospital， Affiliated Hospital of Hubei University of Arts and Science， Xiangyang 441021， China

Received:2023-06-16Revised:2023-10-16Online:2024-04-08Published:2024-05-10
Contact:Wang Yuehua， Email： 510839835@qq.com
Supported by:
Guiding Project of Health Commission of Hubei Province of China(WJ2019F091)

摘要/Abstract

摘要：

定期筛查对于癌症早诊早治至关重要。癌症筛查手段大多繁琐、有侵入性、费用高，特别是进行多器官全面检查时，如何提高常规癌症筛查的速度和有效性仍然是卫生保健领域的重大挑战。多癌早期筛查是一个充满希望的新概念，有助于弥补当前常规癌症筛查的不足。近年来，一些早癌筛查技术已经得到发展，例如检测血液中肿瘤无细胞DNA技术、电子鼻技术以及利用秀丽隐杆线虫作为早期癌症检测工具探测非血液体液如呼出气凝集液和尿液。

关键词:癌症早期检测,电子鼻,秀丽隐杆线虫

Abstract:

Regular cancer screening is crucial for early detection and treatment of cancer. Most cancer screening methods are cumbersome， invasive， and expensive， especially when conducting multi-organ examinations. How to improve the speed and effectiveness of routine cancer screening remains a significant challenge in healthcare. Multi-cancer early detection is a promising concept and a potentially effective solution to the current routine cancer screening methods. In recent years， several multi-cancer early detection technologies have been developed， such as detecting cell-free tumor DNA in blood， electronic nose technology， and using organisms likeCaenorhabditis elegansas early cancer detection tools， with testing samples of non-blood fluids such as exhaled breath condensate and urine.

Key words:Early detection of cancer,Electronic nose,Caenorhabditis elegans

胡婷婷, 王越华. 电子鼻与线虫鼻——新型早期癌症筛查工具[J]. 国际肿瘤学杂志, 2024, 51(4): 223-226.

Hu Tingting, Wang Yuehua. Electronic nose and nematode nose as new tool for early cancer screening[J]. Journal of International Oncology, 2024, 51(4): 223-226.

参考文献25

[1]	Ebell MH, Thai TN, Royalty KJ. Cancer screening recommendations: an international comparison of high income countries[J].Public Health Rev,2018,39: 7. DOI:10.1186/s40985-018-0080-0. pmid:29507820
[2]	di Luccio E, Morishita M, Hirotsu T. C. elegans as a powerful tool for cancer screening[J].Biomedicines,2022,10(10): 2371. DOI:10.3390/biomedicines10102371.
[3]	World Health Organization. Cancer[EB/OL]. [2022-09-08]. https://www.who.int/news-room/fact-sheets/detail/cancer.
[4]	Inaba S, Shimozono N, Yabuki H, et al. Accuracy evaluation of the C. elegans cancer test (N-NOSE) using a new combined method[J].Cancer Treat Res Commun,2021,27: 100370. DOI:10.1016/j.ctarc.2021.100370.
[5]	Markou A, Tzanikou E, Lianidou E. The potential of liquid biopsy in the management of cancer patients[J].Semin Cancer Biol,2022,84: 69-79. DOI:10.1016/j.semcancer.2022.03.013. pmid:35331850
[6]	Bax C, Lotesoriere BJ, Sironi S, et al. Review and comparison of cancer biomarker trends in urine as a basis for new diagnostic pathways[J].Cancers (Basel),2019,11(9): 1244. DOI:10.3390/cancers11091244.
[7]	Daily A, Ravishankar P, Harms S, et al. Using tears as a non-invasive source for early detection of breast cancer[J].PLoS One,2022,17(4): e0267676. DOI:10.1371/journal.pone.0267676.
[8]	Hanna GB, Boshier PR, Markar SR, et al. Accuracy and methodologic challenges of volatile organic compound-based exhaled breath tests for cancer diagnosis: a systematic review and meta-analysis[J].JAMA Oncol,2019,5(1): e182815. DOI:10.1001/jamaoncol.2018.2815.
[9]	Scheepers MHMC, Al-Difaie Z, Brandts L, et al. Diagnostic performance of electronic noses in cancer diagnoses using exhaled breath: a systematic review and meta-analysis[J].JAMA Netw Open,2022,5(6): e2219372. DOI:10.1001/jamanetworkopen.2022.19372.
[10]	Becker R. Non-invasive cancer detection using volatile biomarkers: is urine superior to breath?[J].Med Hypotheses,2020,143: 110060. DOI:10.1016/j.mehy.2020.110060.
[11]	Feil C, Staib F, Berger MR, et al. Sniffer dogs can identify lung cancer patients from breath and urine samples[J].BMC Cancer,2021,21(1): 917. DOI:10.1186/s12885-021-08651-5. pmid:34388977
[12]	Giró Benet J, Seo M, Khine M, et al. Breast cancer detection by analyzing the volatile organic compound (VOC) signature in human urine[J].Sci Rep,2022,12(1): 14873. DOI:10.1038/s41598-022-17795-8. pmid:36050339
[13]	Issitt T, Wiggins L, Veysey M, et al. Volatile compounds in human breath: critical review and meta-analysis[J].J Breath Res,2022,16(2): 024001. DOI:10.1088/1752-7163/ac5230.
[14]	Hu W, Wu W, Jian Y, et al. Volatolomics in healthcare and its advanced detection technology[J].Nano Res,2022,15(9): 8185-8213. DOI:10.1007/s12274-022-4459-3. pmid:35789633
[15]	Anzivino R, Sciancalepore PI, Dragonieri S, et al. The role of a polymer-based E-nose in the detection of head and neck cancer from exhaled breath[J].Sensors (Basel),2022,22(17): 6485. DOI:10.3390/s22176485.
[16]	Kort S, Brusse-Keizer M, Schouwink H, et al. Diagnosing non-small cell lung cancer by exhaled breath profiling using an electronic nose: a multicenter validation study[J].Chest,2023,163(3): 697-706. DOI:10.1016/j.chest.2022.09.042.
[17]	Chung J, Akter S, Han S, et al. Diagnosis by volatile organic compounds in exhaled breath in exhaled breath from patients with gastric and colorectal cancers[J].Int J Mol Sci,2022,24(1): 129. DOI:10.3390/ijms24010129.
[18]	van der Sar IG, Wijbenga N, Nakshbandi G, et al. The smell of lung disease: a review of the current status of electronic nose technology[J].Respir Res,2021,22(1): 246. DOI:10.1186/s12931-021-01835-4.
[19]	Suzuki M, Hattori Y, Saito T, et al. Pond assay for the sensory systems of Caenorhabditis elegans: a novel anesthesia-free method enabling detection of responses to extremely low chemical concentrations[J].Biology (Basel),2022,11(2): 335. DOI:10.3390/biology11020335.
[20]	Asai A, Konno M, Ozaki M, et al. Scent test using Caenorhabditis elegans to screen for early-stage pancreatic cancer[J].Oncotarget,2021,12(17): 1687-1696. DOI:10.18632/oncotarget.28035.
[21]	Kobayashi M, Fujita A, Ogawa T, et al. Caenorhabditis elegans as a diagnostic aid for pancreatic cancer[J].Pancreas,2021,50(5): 673-678. DOI:10.1097/MPA.0000000000001814.
[22]	Kusumoto H, Tashiro K, Shimaoka S, et al. Behavioural response alteration in Caenorhabditis elegans to urine after surgical removal of cancer: Nematode-NOSE (N-NOSE) for postoperative evaluation[J].Biomark Cancer,2019,11: 1179299X19896551. DOI:10.1177/1179299X19896551.
[23]	Ueda Y, Kawamoto K, Konno M, et al. Application of C. elegans cancer screening test for the detection of pancreatic tumor in genetically engineered mice[J].Oncotarget,2019,10(52): 5412-5418. DOI:10.18632/oncotarget.27124.
[24]	Gasparri R, Capuano R, Guaglio A, et al. Volatolomic urinary profile analysis for diagnosis of the early stage of lung cancer[J].J Breath Res,2022,16(4): 046008. DOI:10.1088/1752-7163/ac88ec.
[25]	Lanza E, Di Rocco M, Schwartz S, et al. C. elegans-based chemosensation strategy for the early detection of cancer metabolites in urine samples[J].Sci Rep,2021,11(1): 17133. DOI:10.1038/s41598-021-96613-z. pmid:34429473